SlideShare a Scribd company logo
1 of 16
The many facets of
Acquired Haemophilia
    Wai Keong Wong
     Keith Gomez
79F
• Recurrent Falls and Tiredness
• R Distal Radius # + Swollen Left Knee
• APTT 111 PT12 Fib 5.3
  – APTT 50:50 Mix 37 (not fully corrected)
• Hb 7.3
On Examination
• R Arm Bruise from Axilla to Fingers
• Left Anterior CubitalFossa – Bruised
  – Site of Venepuncture
• Bruising of the L Knee
• Hot Swollen R Knee
• BP 85/45 HR 120 RR 30 Sats 94%
Acquired Haemophilia
• Antibodies against Factor VIII
• Rare
  – Prevalence 344 cases in UK
  – Incidence 60-70 / yr 1-1.5 per million
  – Median Age 74
• Diagnosis
  – Prolonged APTT
  – Does not correct with 50/50
  – Low Factor VIII (IX rarely) + Inhibitor
Stop the
            Bleed




          Objectives

Immune                 Find the
suppres                 Cause
FEIBA         rFVIIa
t½ 8-12 hrs   t½ 2-3 hrs
£4000         £3500
Monitoring bypassing therapy
      Normal            Baseline




   rFVIIa 90 ug/kg   FEIBA 100 IU/kg

                                       7
Underlying Cause
                                                           %
           Autoimmune disorder                            14.1
           Malignancy                                     11.5
           Pregnancy                                       8.9
           Drug-induced                                    3.3
           Transfusion, dermatologic,
             infection, MGUS, other                        7.8
           Idiopathic                                     54.4

Ref: Baudoet al.Blood July 5, 2012 vol. 120 no. 1 39-46
20
                      40
                                      60
                                                 80
                                                      100
                                                            120
                                                                  140
                                                                                160




             0
28/03/2011


04/04/2011


11/04/2011


18/04/2011


25/04/2011
                                                                                                 Prednisolone 60mg




02/05/2011


09/05/2011


16/05/2011
                                                                                                30mg




23/05/2011


30/05/2011
                                                                        Cyclophosphamide 50mg




06/06/2011


13/06/2011


20/06/2011


27/06/2011


04/07/2011


11/07/2011


18/07/2011


25/07/2011


01/08/2011
                           ?Role for IVIg




08/08/2011


15/08/2011
                           ?Role for Rituximab
Complete remission dependent on treatment group.



                                                                    ○ Steroids alone
                                                                    □ Steroids and   Cytotoxics




                 Collins P W et al. Blood 2007;109:1870-1877



©2007 by American Society of Hematology
Inpatient Care

 ‘Routine’
                                  Venepuncture                  Physiotherapy
Observations




               Line Insertion /                  Biopsies and
                  Removal                          Surgery
Venepuncture
Manual Handling
Sites of bleeding in patients with acquired hemophilia.




                    Collins P W et al. Blood 2007;109:1870-1877   Unrelated to FVIII Level
                                                                  Contrast to Haemophilia A
©2007 by American Society of Hematology
Were there warning signs?
• 2 weeks prior, mechanical fall and hit chin + R
  distal radial #
  – APTT 57
• Chin wouldn’t stop bleeding -> A+E
  – Hb 11 APTT 87 -> GP to recheck
  – Haem not consulted. Haem lab did not inform
    Haem on-call
Conclusion
• Rare but important disorder
• Bleeding + High APTT
  – 50/50 Mix does not correct
• Challenge of managing a rare condition
  – Most bleeding episodes may be iatrogenic
  – Cost £20000 / day on agents alone
• Management – Stop the Bleed/ Find the
  underlying cause/ Immuno-suppress

More Related Content

What's hot

Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
derosaMSKCC
 
Hemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasalHemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasal
Angus Shao
 
att4_Rice_Sep07
att4_Rice_Sep07att4_Rice_Sep07
att4_Rice_Sep07
pharmdude
 
Heparin induced thrombocytopenia(hit)
Heparin induced thrombocytopenia(hit)Heparin induced thrombocytopenia(hit)
Heparin induced thrombocytopenia(hit)
Figo Khan
 
Heparin induced thrombocytopenia
Heparin induced thrombocytopeniaHeparin induced thrombocytopenia
Heparin induced thrombocytopenia
derosaMSKCC
 
Laboratory tests of hemostasis and coagulation system (dr ellinor peerschke ...
Laboratory tests of hemostasis and coagulation system (dr  ellinor peerschke ...Laboratory tests of hemostasis and coagulation system (dr  ellinor peerschke ...
Laboratory tests of hemostasis and coagulation system (dr ellinor peerschke ...
derosaMSKCC
 
Laboratory tests of hemostasis and coagulation system
Laboratory tests of hemostasis and coagulation systemLaboratory tests of hemostasis and coagulation system
Laboratory tests of hemostasis and coagulation system
derosaMSKCC
 

What's hot (20)

Trauma induced coagulopathy
Trauma induced coagulopathyTrauma induced coagulopathy
Trauma induced coagulopathy
 
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
 
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
 
Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...
 
Hemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasalHemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasal
 
Hemostasis in txa
Hemostasis in txaHemostasis in txa
Hemostasis in txa
 
Tranexamic Acid
Tranexamic Acid Tranexamic Acid
Tranexamic Acid
 
att4_Rice_Sep07
att4_Rice_Sep07att4_Rice_Sep07
att4_Rice_Sep07
 
Heparine induced thrombocytopenia
Heparine induced thrombocytopeniaHeparine induced thrombocytopenia
Heparine induced thrombocytopenia
 
heparin Resistance
heparin Resistanceheparin Resistance
heparin Resistance
 
Heparin induced thrombocytopenia(hit)
Heparin induced thrombocytopenia(hit)Heparin induced thrombocytopenia(hit)
Heparin induced thrombocytopenia(hit)
 
Heparin Induced Thrombocytopenia Handout
Heparin Induced Thrombocytopenia HandoutHeparin Induced Thrombocytopenia Handout
Heparin Induced Thrombocytopenia Handout
 
Reversal of anticoagulation (joel 31.1.2017)
Reversal of anticoagulation (joel 31.1.2017)Reversal of anticoagulation (joel 31.1.2017)
Reversal of anticoagulation (joel 31.1.2017)
 
Heparin induced thrombocytopenia
Heparin induced thrombocytopeniaHeparin induced thrombocytopenia
Heparin induced thrombocytopenia
 
Massive Transfusion In Trauma
Massive Transfusion In TraumaMassive Transfusion In Trauma
Massive Transfusion In Trauma
 
Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017 Induction treatment in Kidney transplantation chaken 2017
Induction treatment in Kidney transplantation chaken 2017
 
Galactic HF trial
Galactic HF trialGalactic HF trial
Galactic HF trial
 
Laboratory tests of hemostasis and coagulation system (dr ellinor peerschke ...
Laboratory tests of hemostasis and coagulation system (dr  ellinor peerschke ...Laboratory tests of hemostasis and coagulation system (dr  ellinor peerschke ...
Laboratory tests of hemostasis and coagulation system (dr ellinor peerschke ...
 
Heparin induced-thrombocytopenia-in-hemodialysis-patients-dr.-mohammed-abdel-...
Heparin induced-thrombocytopenia-in-hemodialysis-patients-dr.-mohammed-abdel-...Heparin induced-thrombocytopenia-in-hemodialysis-patients-dr.-mohammed-abdel-...
Heparin induced-thrombocytopenia-in-hemodialysis-patients-dr.-mohammed-abdel-...
 
Laboratory tests of hemostasis and coagulation system
Laboratory tests of hemostasis and coagulation systemLaboratory tests of hemostasis and coagulation system
Laboratory tests of hemostasis and coagulation system
 

Similar to The Many Facets of Acquired Haemophilia

Bleeding_and_Coagulation_disorders_2015_2_lectures.pptx
Bleeding_and_Coagulation_disorders_2015_2_lectures.pptxBleeding_and_Coagulation_disorders_2015_2_lectures.pptx
Bleeding_and_Coagulation_disorders_2015_2_lectures.pptx
krishmajindal1
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands disease
Babak Jebelli
 
Child with bleeding problems edited
Child with bleeding problems editedChild with bleeding problems edited
Child with bleeding problems edited
Hui Pheng Neoh
 
Technician report initial testing
Technician report   initial testingTechnician report   initial testing
Technician report initial testing
Laura Gillies
 
Technician report initial testing
Technician report   initial testingTechnician report   initial testing
Technician report initial testing
Laura Gillies
 
Homestasis Surgery
Homestasis SurgeryHomestasis Surgery
Homestasis Surgery
axix
 
Date PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docxDate PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docx
edwardmarivel
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itp
ghalan
 

Similar to The Many Facets of Acquired Haemophilia (20)

Risk stratification version 2
Risk stratification version 2Risk stratification version 2
Risk stratification version 2
 
Coagulation .doc
Coagulation .docCoagulation .doc
Coagulation .doc
 
Hemophilia Case Study
Hemophilia Case StudyHemophilia Case Study
Hemophilia Case Study
 
Bleeding_and_Coagulation_disorders_2015_2_lectures.pptx
Bleeding_and_Coagulation_disorders_2015_2_lectures.pptxBleeding_and_Coagulation_disorders_2015_2_lectures.pptx
Bleeding_and_Coagulation_disorders_2015_2_lectures.pptx
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands disease
 
Hemophilia.pdf
Hemophilia.pdfHemophilia.pdf
Hemophilia.pdf
 
Child with bleeding problems edited
Child with bleeding problems editedChild with bleeding problems edited
Child with bleeding problems edited
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands disease
 
Erythropoietins (Epoetins)
Erythropoietins (Epoetins)Erythropoietins (Epoetins)
Erythropoietins (Epoetins)
 
Zoulim fz traitement vhb du16
Zoulim fz traitement vhb du16 Zoulim fz traitement vhb du16
Zoulim fz traitement vhb du16
 
Technician report initial testing
Technician report   initial testingTechnician report   initial testing
Technician report initial testing
 
Technician report initial testing
Technician report   initial testingTechnician report   initial testing
Technician report initial testing
 
Homestasis Surgery
Homestasis SurgeryHomestasis Surgery
Homestasis Surgery
 
Coagulation disorders
Coagulation disordersCoagulation disorders
Coagulation disorders
 
Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015
Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015
Moreau r betabloquants_non_selectifs_et_cirrhose_hepatique_fev2015
 
Date PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docxDate PRE POST PRE POSTna na  na na   .docx
Date PRE POST PRE POSTna na  na na   .docx
 
DVT Presentation.ppt
DVT Presentation.pptDVT Presentation.ppt
DVT Presentation.ppt
 
23 Ppt Itp
23 Ppt Itp23 Ppt Itp
23 Ppt Itp
 
VTE.pptx
VTE.pptxVTE.pptx
VTE.pptx
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediatesBMK Glycidic Acid (sodium salt)  CAS 5449-12-7 Pharmaceutical intermediates
BMK Glycidic Acid (sodium salt) CAS 5449-12-7 Pharmaceutical intermediates
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 

The Many Facets of Acquired Haemophilia

  • 1. The many facets of Acquired Haemophilia Wai Keong Wong Keith Gomez
  • 2. 79F • Recurrent Falls and Tiredness • R Distal Radius # + Swollen Left Knee • APTT 111 PT12 Fib 5.3 – APTT 50:50 Mix 37 (not fully corrected) • Hb 7.3
  • 3. On Examination • R Arm Bruise from Axilla to Fingers • Left Anterior CubitalFossa – Bruised – Site of Venepuncture • Bruising of the L Knee • Hot Swollen R Knee • BP 85/45 HR 120 RR 30 Sats 94%
  • 4. Acquired Haemophilia • Antibodies against Factor VIII • Rare – Prevalence 344 cases in UK – Incidence 60-70 / yr 1-1.5 per million – Median Age 74 • Diagnosis – Prolonged APTT – Does not correct with 50/50 – Low Factor VIII (IX rarely) + Inhibitor
  • 5. Stop the Bleed Objectives Immune Find the suppres Cause
  • 6. FEIBA rFVIIa t½ 8-12 hrs t½ 2-3 hrs £4000 £3500
  • 7. Monitoring bypassing therapy Normal Baseline rFVIIa 90 ug/kg FEIBA 100 IU/kg 7
  • 8. Underlying Cause % Autoimmune disorder 14.1 Malignancy 11.5 Pregnancy 8.9 Drug-induced 3.3 Transfusion, dermatologic, infection, MGUS, other 7.8 Idiopathic 54.4 Ref: Baudoet al.Blood July 5, 2012 vol. 120 no. 1 39-46
  • 9. 20 40 60 80 100 120 140 160 0 28/03/2011 04/04/2011 11/04/2011 18/04/2011 25/04/2011 Prednisolone 60mg 02/05/2011 09/05/2011 16/05/2011 30mg 23/05/2011 30/05/2011 Cyclophosphamide 50mg 06/06/2011 13/06/2011 20/06/2011 27/06/2011 04/07/2011 11/07/2011 18/07/2011 25/07/2011 01/08/2011 ?Role for IVIg 08/08/2011 15/08/2011 ?Role for Rituximab
  • 10. Complete remission dependent on treatment group. ○ Steroids alone □ Steroids and Cytotoxics Collins P W et al. Blood 2007;109:1870-1877 ©2007 by American Society of Hematology
  • 11. Inpatient Care ‘Routine’ Venepuncture Physiotherapy Observations Line Insertion / Biopsies and Removal Surgery
  • 14. Sites of bleeding in patients with acquired hemophilia. Collins P W et al. Blood 2007;109:1870-1877 Unrelated to FVIII Level Contrast to Haemophilia A ©2007 by American Society of Hematology
  • 15. Were there warning signs? • 2 weeks prior, mechanical fall and hit chin + R distal radial # – APTT 57 • Chin wouldn’t stop bleeding -> A+E – Hb 11 APTT 87 -> GP to recheck – Haem not consulted. Haem lab did not inform Haem on-call
  • 16. Conclusion • Rare but important disorder • Bleeding + High APTT – 50/50 Mix does not correct • Challenge of managing a rare condition – Most bleeding episodes may be iatrogenic – Cost £20000 / day on agents alone • Management – Stop the Bleed/ Find the underlying cause/ Immuno-suppress

Editor's Notes

  1. Clotting Cascade ---- Simplified
  2. Our lady had a eosinophilicpneumoniti, Autoimmune Screen, History and Clinical Examination, CT NCAP
  3. There is a 20% chance of relapse?Less chance of Relapse with Rituximab?